Methotrexate megadosage followed by folate rescue. I. A study in clearance patterns
- PMID: 1085404
Item in Clipboard
Methotrexate megadosage followed by folate rescue. I. A study in clearance patterns
Med J Aust.
.
Abstract
Plasma clearance rates of methotrexate (MTX) have been determined in five patients given an infusion of 3,000 mg of MTX over six hours, followed by folate rescue 24 hours after the commencement of infusion. Results presented indicate that maintenance of high MTX concentrations and potential toxicity could not be related to age, body weight or surface area.
Similar articles
-
[Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].Wien Klin Wochenschr. 1981 Apr 3;93(7):236-40. Wien Klin Wochenschr. 1981. PMID: 7020262 German.
-
[The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].Klin Padiatr. 1990 Sep-Oct;202(5):340-6. doi: 10.1055/s-2007-1025542. Klin Padiatr. 1990. PMID: 2214594 German.
-
High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.Pediatr Blood Cancer. 2004 Jul;43(1):17-22. doi: 10.1002/pbc.20032. Pediatr Blood Cancer. 2004. PMID: 15170885 Clinical Trial.
-
Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.Ther Drug Monit. 1980;2(2):177-85. Ther Drug Monit. 1980. PMID: 6762711 Review.
-
[Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].Gan To Kagaku Ryoho. 1996 Dec;23(14):1901-6. Gan To Kagaku Ryoho. 1996. PMID: 8978794 Review. Japanese.
Cited by
-
An indication of possible impending toxicity during moderately high dose methotrexate infusions.Br J Clin Pharmacol. 1978 Dec;6(6):551-2. doi: 10.1111/j.1365-2125.1978.tb00887.x. Br J Clin Pharmacol. 1978. PMID: 569491 Free PMC article. No abstract available.
-
The protein binding of methotrexate by the serum of normal subjects.Eur J Clin Pharmacol. 1979 Jun 12;15(5):363-6. doi: 10.1007/BF00558441. Eur J Clin Pharmacol. 1979. PMID: 456408